These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20733007)

  • 1. Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats.
    Serpi R; Tolonen AM; Huusko J; Rysä J; Tenhunen O; Ylä-Herttuala S; Ruskoaho H
    Cardiovasc Res; 2011 Jan; 89(1):204-13. PubMed ID: 20733007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
    Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
    Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.
    Tang J; Wang J; Kong X; Yang J; Guo L; Zheng F; Zhang L; Huang Y; Wan Y
    Exp Cell Res; 2009 Dec; 315(20):3521-31. PubMed ID: 19800880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
    Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
    Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R; Tan BK; Punn A; Chen J; Randeva HS
    Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
    Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.
    Rengo G; Cannavo A; Liccardo D; Zincarelli C; de Lucia C; Pagano G; Komici K; Parisi V; Scala O; Agresta A; Rapacciuolo A; Perrone Filardi P; Ferrara N; Koch WJ; Trimarco B; Femminella GD; Leosco D
    Circ Heart Fail; 2013 Nov; 6(6):1259-67. PubMed ID: 24029661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.
    Zentilin L; Puligadda U; Lionetti V; Zacchigna S; Collesi C; Pattarini L; Ruozi G; Camporesi S; Sinagra G; Pepe M; Recchia FA; Giacca M
    FASEB J; 2010 May; 24(5):1467-78. PubMed ID: 20019242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
    Kupatt C; Hinkel R; Pfosser A; El-Aouni C; Wuchrer A; Fritz A; Globisch F; Thormann M; Horstkotte J; Lebherz C; Thein E; Banfi A; Boekstegers P
    J Am Coll Cardiol; 2010 Jul; 56(5):414-22. PubMed ID: 20650363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy.
    Pepe M; Mamdani M; Zentilin L; Csiszar A; Qanud K; Zacchigna S; Ungvari Z; Puligadda U; Moimas S; Xu X; Edwards JG; Hintze TH; Giacca M; Recchia FA
    Circ Res; 2010 Jun; 106(12):1893-903. PubMed ID: 20431055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms.
    Moilanen AM; Rysä J; Mustonen E; Serpi R; Aro J; Tokola H; Leskinen H; Manninen A; Levijoki J; Vuolteenaho O; Ruskoaho H
    Circ Heart Fail; 2011 Jul; 4(4):483-95. PubMed ID: 21558448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.
    Kinnunen K; Korpisalo P; Rissanen TT; Heikura T; Viita H; Uusitalo H; Ylä-Herttuala S
    Acta Physiol (Oxf); 2006 Aug; 187(4):447-57. PubMed ID: 16866776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
    Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
    Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
    Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
    J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.